Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

Novel hemoregulatory compounds from SKB

July 10, 1997

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

SmithKline Beecham focuses on hemoregulatory compounds

July 9, 1997

Senetek seeks Danish approval of erectile dysfunction therapy

July 8, 1997

Bioisosteres of sulfonylureas prepared by Belgian investigators

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...